Haploidentical Stem Cell Transplantation Followed by NK Cell Infusion in Patients With High-risk Solid Tumors Who Failed Autologous Stem Cell Transplantation
Latest Information Update: 03 Oct 2021
At a glance
- Drugs MG 4101 (Primary)
- Indications Ewing's sarcoma; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma
- Focus Adverse reactions
- 17 Sep 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019.
- 15 Jun 2016 New trial record
- 02 Jun 2016 Status changed from active, no longer recruiting to completed, as reported by Oxford BioMedica media release.